title: Reversible induction of rat hepatoma cell polarity with bile acids.
abstract: A dynamic model for inducing and isolating polarized cell colonies from differentiated rat hepatoma was established with chenodeoxycholic acid (CDCA). Cells were treated with 75 microM CDCA in a 1% solvent mix (DMSO/ethanol: 0.5%/0.5%) for 11 days and positive Fao-BA1 and C2rev7-BA1 clones were isolated, respectively, from Fao and C2rev7. Cell polarization in these two clones was demonstrated by (i) the detection of (gamma)-glutamyl transpeptidase activity (gamma)-GT) and the presence of specific proteins, namely aminopeptidase N (APN), bile acid export pump (Bsep), multidrug resistance-associated protein 2 (Mrp2) at the canalicular pole, (ii) the expression of tight junction (ZO-1) and basolateral (1-18) marker proteins, (iii) the presence of regular microvilli in the cavities sealed by tight junctions, and (iv) functional bile canaliculi-like structures with the capacity to metabolise and secrete carboxyfluorescein diacetate dye. The polarized phenotype was maintained for more than 200 cell generations in the presence of CDCA and could be modulated by cell density or omitting the inducing agent. Hence this cellular model is well suited for studies on hepatic differentiation, polarization and bile salt trafficking with therapeutic implications.
authors.affiliation: INSERM U347, 94276 Kremlin-Bicêtre cedex, France. kimng@kb.inserm.fr
authors.forename: K H
authors.initials: KH
authors.lastname: Ng
authors.forename: C
authors.initials: C
authors.lastname: Le Goascogne
authors.forename: E
authors.initials: E
authors.lastname: Amborade
authors.forename: B
authors.initials: B
authors.lastname: Stieger
authors.forename: J
authors.initials: J
authors.lastname: Deschatrette
mesh_terms: D000818:Animals; D018826:CD13 Antigens / Q000032:analysis / Q000378:metabolism; D006528:Carcinoma, Hepatocellular; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D016764:Cell Polarity / Q000187:drug effects* / Q000502:physiology; D002635:Chenodeoxycholic Acid / Q000494:pharmacology*; D005452:Fluoresceins / Q000493:pharmacokinetics; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D008565:Membrane Proteins / Q000032:analysis; D008854:Microscopy, Electron; D024101:Mitochondrial Proteins; D010750:Phosphoproteins / Q000032:analysis; D051381:Rats; D012269:Ribosomal Proteins / Q000032:analysis; D029701:Saccharomyces cerevisiae Proteins; D019108:Tight Junctions / Q000737:chemistry; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure; D062826:Zonula Occludens-1 Protein; D005723:gamma-Glutamyltransferase / Q000032:analysis / Q000378:metabolism
chemical_list: D005452:Fluoresceins; D005765:Gastrointestinal Agents; C093947:MRP2 protein, S cerevisiae; D008565:Membrane Proteins; D024101:Mitochondrial Proteins; D010750:Phosphoproteins; D012269:Ribosomal Proteins; D029701:Saccharomyces cerevisiae Proteins; C569044:Tjp1 protein, rat; D062826:Zonula Occludens-1 Protein; D002635:Chenodeoxycholic Acid; D005723:gamma-Glutamyltransferase; D018826:CD13 Antigens; C018506:diacetylfluorescein